|
Sun Pharmaceutical Industries Ltd drops for fifth straight session> |
|
Board of Sun Pharmaceuticals Industries recommends final dividend> |
|
Sun Pharmaceutical Industries consolidated net profit rises 26.24% in the March 2026 quarter> |
|
Sun Pharma Q4 PAT jumps 26% YoY to Rs 2,714 cr> |
|
Sun Pharmaceuticals Industries to declare Quarterly Results> |
|
Sun Pharmaceutical receives credit ratings from CRISIL and ICRA> |
|
Sun Pharmaceutical Industries Ltd spurts 0.33%, gains for fifth straight session> |
|
Sun Pharma surges post deal to acquire US-based pharmaceutical company Organon for $3.99 billion> |
|
Sun Pharmaceuticals enters definitive agreement to acquire Organon> |
|
Sun Pharma incorporates subsidiary in U.S.> |